Literature DB >> 16700792

Characteristics of basal cell carcinoma amongst Asians in Singapore and a comparison between completely and incompletely excised tumors.

Boon Kee Goh1, Por Ang, Ying Juan Wu, Chee Leok Goh.   

Abstract

BACKGROUND: Most published series of basal cell carcinomas (BCCs) are based on Caucasian populations. Very little is known about the characteristics of incompletely excised BCCs in Asians.
OBJECTIVES: This study examines the characteristics of BCCs in Asian residents in Singapore, and compares incompletely with completely excised tumors after conventional surgical excision. PATIENTS AND METHODS: A retrospective study was conducted using the case records of patients who had a primary BCC excised at the National Skin Centre between 1991 and 1995.
RESULTS: A total of 185 histologically confirmed BCCs were recorded in 166 patients (male to female ratio, 0.95; mean age, 70.9 years). The highest proportion (27.1%) was in the 81-90-year age group. Compared with census data, a significantly higher proportion of patients with BCCs were Chinese (P < 0.001). The tumors averaged 12.0 mm in diameter and the majority (84.3%) were located on the head and neck. In 28 lesions (15.1%), the tumors were incompletely excised, with those on the nose and nasolabial folds being most frequent. Incompletely excised BCCs were more likely than completely excised lesions to be located on the mid-face and trunk (P = 0.003), but there was no significant correlation with tumor size, tumor duration, or patient age, race, and gender. The overall recurrence rate was 1.6% over a mean follow-up time of 74 months.
CONCLUSIONS: BCCs are more common amongst Chinese in Singapore and occur chiefly in the elderly. Conventional surgical excision with margin control achieves a satisfactory tumor clearance rate of 84.9%. Incomplete excision is associated with tumor location on the mid-face and trunk rather than tumor size or duration.

Entities:  

Mesh:

Year:  2006        PMID: 16700792     DOI: 10.1111/j.1365-4632.2004.02515.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Pigmented Basal cell carcinoma: a clinical variant, report of two cases.

Authors:  Deepadarshan K; Mallikarjun M; Noshin N Abdu
Journal:  J Clin Diagn Res       Date:  2013-12-15

2.  Study to determine whether intraoperative frozen section biopsy improves surgical treatment of non-melanoma skin cancer.

Authors:  Giovanni Nicoletti; Federica Brenta; Alberto Malovini; Gaetano Musumarra; Silvia Scevola; Angela Faga
Journal:  Mol Clin Oncol       Date:  2012-12-14

Review 3.  Surgical treatment of basal cell carcinoma: an algorithm based on the literature.

Authors:  Flávio Barbosa Luz; Camila Ferron; Gilberto Perez Cardoso
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

4.  Basal cell carcinoma of the head and neck region: a retrospective analysis of completely excised 331 cases.

Authors:  Duriye Deniz Demirseren; Candemir Ceran; Berrak Aksam; Mustafa Erol Demirseren; Ahmet Metin
Journal:  J Skin Cancer       Date:  2014-04-17

5.  Different Anatomical Distribution of Basal Cell Carcinoma Subtypes in Iranian Population: Association between Site and Subtype.

Authors:  Alireza Ghanadan; Pejman Abdollahi; Mehrshad Rabet; Zahra Naraghi; Mohammad Amin Abbasi; Homayun Moslehi; Ata Abbasi
Journal:  Ann Dermatol       Date:  2014-09-26       Impact factor: 1.444

6.  Basal cell carcinoma in asians: a retrospective analysis of ten patients.

Authors:  Michael G Moore; Richard G Bennett
Journal:  J Skin Cancer       Date:  2012-07-05

7.  Characteristics of Mixed Type Basal Cell Carcinoma in Comparison to Other BCC Subtypes.

Authors:  A Ghanadan; A Abbasi; M Rabet; P Abdollahi; Ma Abbasi
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

8.  Treatment of Pigmented Basal Cell Carcinoma with 3 mm Surgical Margin in Asians.

Authors:  Shang-Hung Lin; Yu-Wen Cheng; Yi-Chien Yang; Ji-Chen Ho; Chih-Hung Lee
Journal:  Biomed Res Int       Date:  2016-08-29       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.